Trial intelligence / Profile preview

Paclitaxel Poliglumex with Cetuximab and RT in Advanced Head and Neck Cancer

NCT00660218Phase 2Completed

Sponsor
Upstate Medical University
Start
Mar 2008
Primary completion
Dec 2016
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of paclitaxel poliglumex in head and neck squamous cell carcinoma (HNSCC), sponsored by Upstate Medical University. Started Mar 2008; status: completed.

02

Drugs

paclitaxel poliglumex
03

Conditions

head and neck squamous cell carcinoma (HNSCC)

Beyond the preview

Go deeper on NCT00660218.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00660218.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call